FitLife Brands is executing a successful roll-up strategy in the supplement industry, highlighted by its acquisition of Irwin Naturals. The Irwin deal could double FTLF's revenue in 2026, with management guiding for $120M+ revenue and $25M adjusted EBITDA next year. Risks include whey protein shortages, margin pressure, and private-label competition, but FTLF's growth potential appears underappreciated by the market.
FitLife Brands, Inc. ( FTLF ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Dayton Judd - Chairman & CEO Conference Call Participants Ryan Meyers - Lake Street Capital Markets, LLC, Research Division Sean McGowan - ROTH Capital Partners, LLC, Research Division Samir Patel - Askeladden Capital Management LLC Presentation Operator Good afternoon, and welcome to the FitLife Brands Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Dan Judd, CEO of FitLife Brands.
FitLife Brands (FTLF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
FitLife Brands, Inc. (NASDAQ:FTLF ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Dayton Robert Judd - Chairman & CEO Ryan Hansen - Executive Vice President Conference Call Participants Ryan Robert Meyers - Lake Street Capital Markets, LLC, Research Division Sean Patrick McGowan - ROTH Capital Partners, LLC, Research Division Samir Patel - Askeladden Capital Management LLC Operator Good day, and welcome to the FitLife Brands Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Dayton Judd, CEO at FitLife.
Q1 2025 results were unimpressive but aligned with expectations; Muscle Pharm's turnaround remains elusive despite management efforts. Management is actively seeking M&A opportunities, targeting niche brands due to heavy competition from larger players and private equity. Q2 is expected to show growth, driven by market resilience, easier comps, and early signs of revenue and EBITDA improvement.
FitLife Brands, Inc. (NASDAQ:FTLF ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Dayton Judd - Chief Executive Officer Jakob York - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Sean McGowan - ROTH Capital Partners James Bogan - Legend Capital Samir Patel - Askeladden Capital William Anderson - Bard Associates Operator Good day and welcome to the FitLife brand's first quarter 2025 financial results conference call. At this time, all participants have been placed on a listen only mode.
Fitlife Brands continues to deliver strong financial results, showcasing robust revenue growth and profitability. FTLF's strategic acquisitions and innovative product lines drive its competitive edge and market expansion. Management's effective execution and focus on operational efficiency contribute to sustained shareholder value.
FitLife Brands (FTLF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
FitLife Brands, Inc. (NASDAQ:FTLF ) Q4 2024 Results Conference Call March 27, 2025 4:30 PM ET Company Participants Dayton Judd - Chief Executive Officer Jakob York - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Samir Patel - Askeladden Capital James Bogan - Legend Capital Igor Novgorodtsev - Lares Capital Sean McGowan - ROTH Capital Partners Operator Good day, and welcome to the FitLife Brands' Fourth Quarter 2024 Financial Results. At this time, all participants have been placed on listen-only mode and we will be open the floor for questions and comments following the presentation.
FitLife Brands (FTLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FitLife is in the 7th year of its turnaround, having built a strong history of success during this time. The core business offers attractive economics with a strong free cash flow generative capacity. Management has strung together a number of value-accretive acquisitions recently, and the prospect of this continuing into the future offers major potential upside for investors.
FitLife Brands focuses on sports supplements, a complex market highlighted by the lack of differentiation. While Q3 results were worse than analysts expected, there's still double-digit growth and margin optimization going on. Growth and margins should improve as customers move from wholesale to online channels. Additionally, business segments that weren't profitable were closed during Q3.